Cardiac Manifestations in Patients with COVID-19: A Scoping Review

Sasha Peiris1,2, Pedro Ordunez3, Donald DiPette4

  • 1Incident Management Systems for COVID-19, Pan American Health Organization, Washington, DC, USA.

Global Heart
|February 17, 2022
PubMed

Insights

COVID-19 frequently impacts the heart, causing cardiac injury, arrhythmias, and acute coronary syndromes, particularly in severe cases. Further research is needed to clarify the role of viral infection versus inflammation and guide treatment.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Coronavirus disease 2019 (COVID-19) primarily affects the lungs but frequently involves the heart.
  • Cardiac manifestations are prevalent in COVID-19 patients, impacting prognosis and outcomes.
  • Understanding these cardiac complications is crucial for managing COVID-19 patients.

Purpose of the Study:

  • To review the literature on cardiac manifestations in adult COVID-19 patients.
  • To summarize the frequency and types of cardiac complications associated with COVID-19.
  • To analyze clinical parameters, biomarkers, and pharmacotherapy outcomes related to cardiac involvement in COVID-19.

Main Methods:

  • A scoping review of systematic reviews was conducted.
  • Databases searched included Embase, PubMed, Epistomonikos, Medrxiv, and BioRxiv up to November 2020.
  • Sixty-three systematic reviews were included and their findings extracted.

Main Results:

  • Acute cardiac injury occurred in 15%–33% of patients.
  • Arrhythmias were more frequent in severe COVID-19 (33.0%–48.0%) compared to non-severe cases (3.1%–6.9%).
  • Acute coronary syndromes and myocarditis were also significant complications; Renin-angiotensin-aldosterone system inhibitors (RAASI) showed no association with COVID-19 outcomes.

Conclusions:

  • Cardiac injury, arrhythmias, myocarditis, and acute coronary syndrome are significant complications of COVID-19, linked to disease severity and mortality.
  • Further research is needed to differentiate between direct viral myocarditis and inflammation-induced cardiac injury.
  • Heterogeneous results from systematic reviews highlight the need for randomized trials to establish optimal pharmacotherapy.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
54
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
58
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
67
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
49
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
98